Rabeprazole Sodium 20MG Injection

Rabeprazole Sodium 20 mg Injection
Rapid Relief. Reliable Acid Control. Right When It’s Needed Most.

Rabeprazole Sodium Injection 20 mg is a powerful, fast-acting proton pump inhibitor (PPI) designed for IV administration in hospitalized patients unable to take oral medication. It effectively suppresses gastric acid secretion, providing prompt relief and control in critical care settings.

Fast-Acting Acid Suppression – Achieves rapid control of gastric acid for immediate symptom relief.
Ideal for NPO Patients – Tailored for patients who cannot take oral therapy due to vomiting, surgery, or critical illness.
Trusted PPI Mechanism – Irreversibly inhibits H⁺/K⁺-ATPase in gastric parietal cells, reducing both basal and stimulated acid output.
Broad Clinical Use – Effective in managing GERD, Zollinger-Ellison Syndrome, peptic ulcers, and acid-related complications in ICU patients

Indications:
Short-term treatment of acid-related disorders in patients unable to take oral therapy.

Important Safety Information:
Use with caution in patients with severe hepatic impairment. Long-term PPI use may be associated with risks such as vitamin B12 deficiency, hypomagnesemia, and increased fracture risk. Monitor therapy duration and patient response closely.